Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.100
-0.080 (-3.67%)
At close: Feb 21, 2025, 4:00 PM
2.140
+0.040 (1.90%)
After-hours: Feb 21, 2025, 4:30 PM EST
Compugen Employees
Compugen had 68 employees as of December 31, 2023. The number of employees decreased by 1 or -1.45% compared to the previous year.
Employees
68
Change (1Y)
-1
Growth (1Y)
-1.45%
Revenue / Employee
$880,176
Profits / Employee
$23,515
Market Cap
188.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CGEN News
- 4 days ago - Compugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025 - PRNewsWire
- 4 days ago - Compugen: Immuno-Oncology Innovator Poised For A Comeback - Seeking Alpha
- 18 days ago - Compugen to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 6 weeks ago - Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors - PRNewsWire
- 3 months ago - Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies - PRNewsWire
- 3 months ago - Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Compugen Reports Third Quarter 2024 Results - PRNewsWire
- 3 months ago - Compugen to Participate in Stifel 2024 Healthcare Conference - PRNewsWire